Hoth Therapeutics, Inc.
- HOTH
- NASDAQ
- Biotechnology
- Dermatology Therapeutics
- Biotech (Skin Disorders)
$0.80
Today −2.22%Quote Aug 5, 2026, 07:59 PM UTC
−29.36%over the last month
Max drawdown −30.4%From 1-month high −29.4%3 months +7.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Hoth Therapeutics
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
6
Market value
$16.5M
Approximate share count
Floor
$0.79
1.4% below price
Resistance
$0.84
4.8% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about HOTHPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free